Start studying Farmacos Mucoliticos. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Español; |; 5 Documents; |; Views. Farmacología de los antitusígenos, mucolíticos y expectorantes Share. tos farmacos · estefania · tos farmacos. Laboratorio Elea es una empresa argentina que desde investiga, produce y distribuye medicamentos confiables para diversas especialidades médicas.
|Published (Last):||5 October 2006|
|PDF File Size:||13.23 Mb|
|ePub File Size:||7.5 Mb|
|Price:||Free* [*Free Regsitration Required]|
Sociedade Brasileira de Pneumologia e Tisiologia. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.
Prevalence and progression of osteoporosis in patients with COPD: Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: Inhaled corticosteroids vs placebo for preventing COPD exacerbations: The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease.
Combination therapy in COPD: Early onset of mucopiticos of salmeterol and muvoliticos propionate in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease.
No entanto, Calverley et al. Survival with tiotropium compared to long-acting Betaagonists in Chronic Obstructive Pulmonary Disease. Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Inhaled corticosteroids faracos the risk of fracture in chronic obstructive pulmonary disease. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD.
Broncodilatadores, Antitusígenos y Expectorantes. by Anahi Corona on Prezi
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: Eur Rev Med Pharmacol Sci. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Ther Adv Respir Dis.
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Resultados similares foram descritos por Welte et al.
Vademecum de Argentina – Principio activo: AMBROXOL CLEMBUTEROL
Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease. Por sua vez, Macie et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Evaluation of withdrawal of maintenance tiotropium in COPD.
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.
No estudo far,acos Ernst et al. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: Rubin, Antonio George de M.
Inhaled corticosteroids in chronic obstructive pulmonary disease: Short-term effects of montelukast in stable patients with moderate to severe COPD. Comparative safety of long-acting inhaled bronchodilators: Singh S, Loke YK. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: No entanto, Hanania et al.
La Primer Guia Online de Medicamentos Argentinos
Segundo Rennard et al. Prim Care Respir J. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Em termos mucoliicos, avaliado em 24 ou 52 semanas, o aumento foi discreto, variando de 24 a 74 mL. I Professora Titular de Pneumologia. J Gen Intern Med. Entretanto, esses resultados devem ser interpretados com cautela.
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Decramer M, Cooper CB. Withdrawal of inhaled corticosteroids in people with COPD in primary care: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: Respiratory medications and the risk of cardiac arrhythmias.